Remembering the Past
Release time:
2020-08-14
Memories of Past
■ Qiubin Pharmaceutical Factory Wang Haibin
Sun and Moon are like flies. It has been more than 10 20 years since it entered the peak. It was in the late 1990 s. With the deepening of reform and opening up and the restructuring of state-owned enterprises, many employees of state-owned enterprises, including me, were faced with life choices. At that time, there were many employment plans to choose from. I chose Jianfeng Group, because Jianfeng was the only listed company at the same level in Jinhua City at that time, and many young people dreamed of entering. Shortly after my resume was submitted, I successfully received the notice to go to work. At that time, I was very excited and felt that I had a platform to struggle and rely on.
Shortly after I went to work at the peak, I was assigned to the preparatory group of the Pharmaceutical Development Company to engage in the "Special New" disinfectant project transferred from Tianjin Medical Institute. In those years, due to the macro-control of national infrastructure projects and the depression of the cement industry, the group company made a strategic plan to enter the pharmaceutical industry. "Special New" was the first project of Jianfeng Pharmaceutical Development Company, and its significance can be imagined. We are all very excited to be the first batch of workers in the peak medical project, and we also feel the great burden and responsibility on our shoulders.
At that time, the personnel of the project team were basically transferred from outside, including Huang Fu Xiaosheng, a government cadre from Lanxi City, Zheng Yinghua, a process engineer, Wang Yulin, an equipment engineer, Huang Chaoyun and Yang Xiaojuan, chief engineers of the original dyeing and chemical plant, and Li Chengxiang, who graduated from Peking University. These new peak people from all over the world have a common wish, hoping that through the team and their own efforts, the project will be put into effect as soon as possible and contribute to the diversified development of the peak. Some of these former colleagues have retired, some have left the peak, and the memory of them has gradually blurred over time, but the past of those who worked together is still fresh in my mind. During the period of
, the colleagues of the project team worked hard according to the division of labor, day and night. Like everyone else, I do everything well. After careful study and calculation of the pilot scheme and design drawings submitted by Tianjin Medical Institute, according to the accumulation of previous work, the process flow chart with control points and the layout of equipment level and elevation are re-optimized and designed. The process equipment is arranged three-dimensionally according to the reaction steps and operation units. The plant space is reasonably utilized, and the equipment operation, maintenance and production control are more convenient and reliable.
The work during the trial production period is even more complicated. In addition to debugging the machine, we also need to organize raw and auxiliary materials, formulate process regulations, carry out staff training, prepare the trial production plan, etc. Everyone is very busy. The most worrying thing is that the project involves many flammable, explosive, toxic and hazardous chemicals such as toluene, chlorobenzene, n-hexane, ethanol, acetic acid, etc. At that time, the hydrogenation reduction and diazotization reactions in the production process have now been The national safety supervision department determines that it is a dangerous production process, and the requirements for fire and explosion prevention are particularly high. Most of our operators are transferred from cement plants and lack understanding of chemical production. Although they have conducted strict training and assessment before, they have no perceptual knowledge of hazardous chemicals, and they are often careless and random in their work. As a result, several small safety production accidents and attempted accidents occurred. In view of these situations, we have strengthened post inspection and hidden danger investigation, strengthened safety education, training and assessment, especially through strict implementation of hot work, inspection and maintenance and other work permit systems, and strengthened the inspection and assessment of "three violations" to prevent the occurrence of more accidents. Looking back on those days, it was precisely because we practiced the peak spirit of "unity and struggle, truth-seeking and innovation, determination to rise to the top, and forever climbing the peak" that we could complete the project design, equipment installation and trial production in less than half a year.
Although "Texin" was discontinued later due to market changes and improved management requirements, the pace of development of our peak pharmaceutical industry has not stopped. The product "Shu Jiaqing" of the Jiangnan Factory of Dier Pharmaceutical, a joint venture with Dier Pharmaceutical, is sold well in the north and south of the Yangtze River. The merger of Jinhua Biochemical Pharmaceutical Factory and the registration of Zhejiang Jianfeng Pharmaceutical Co., Ltd. have entered a healthy development track since then. With the cephalosporin powder injection preparation workshop, solid preparation workshop and Qiubin Pharmaceutical Factory of Jiangnan Factory of Jianfeng Pharmaceutical Co., Ltd. successively completed and put into operation, new products such as azithromycin, gatifloxacin, Lester, paroxetine and cefmenoxime were successively introduced, and Jinxi Factory, which is in line with international counterparts, was built in 2014 . The enterprise is growing day by day, the technology and equipment are becoming more and more advanced, and the efficiency is getting better and better. As a participant who has witnessed the development of Jianfeng Pharmaceutical from scratch, from small to large, and from weak to strong, I have witnessed the leaders and colleagues who have worked hard for this all the way, and also shared the achievements and joy brought by the development of the enterprise. I deeply realize that only when the enterprise develops can we realize our ideals; only when the employees of the enterprise work hard can the enterprise develop. The individual is a seed, the enterprise is the fertile land, the seed only buried in the fertile land, it is possible to thrive.
Past is like smoke, years are like songs. On the 33rd anniversary of peak start-up 60#, recalling these past events, I am deeply gratified that I decided to come to peak, and proud that I am a peak person! Dripping water en Yongquan newspaper, a mi en thousand dou also. Thanks to the peak for giving us such a platform for development, and thanks to the peak leadership team that led us all the way forward. As an old employee, I will try my best to stand on the last shift. I hope that the young scientific and technological workers of the peak will cherish the development platform provided by the enterprise, motivate themselves with the spirit of the peak, continue to innovate, and strive to create a beautiful century-old peak!
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31